Clinical Trial Update: Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

View source ↗

Summary

This clinical trial update reports pre-approval, single-patient expanded access for ritlecitinib (PF-06651600) in a patient with alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Pfizer | Conditions: Alopecia Areata | Status: AVAILABLE